Zhengxiang Han

Ivonescimab versus pembrolizumab for PD-L1-positive non-small cell lung cancer (HARMONi-2): a randomised, double-blind, phase 3 study in China

Anwen Xiong, Lei Wang, Jianhua Chen et al. · The Lancet · 2025 · 90 citations

Medicine, Immunology, Pathology +6

Chinese medicine formula Kai-Xin-San ameliorates depression-like behaviours in chronic unpredictable mild stressed mice by regulating gut microbiota-inflammation-stress system

Cheng Cao, Mengqiu Liu, Suchen Qu et al. · Journal of Ethnopharmacology · 2020 · 78 citations

Inflammation, Psychoneuroimmunology, Dysbiosis +14

VEGF-A/Neuropilin 1 Pathway Confers Cancer Stemness via Activating Wnt/β-Catenin Axis in Breast Cancer Cells

Lansheng Zhang, Hongmei Wang, Caihong Li et al. · Cellular Physiology and Biochemistry · 2017 · 75 citations · Full text

Breast Oncology, Cancer Biology, Tumor Biology +16

Chinese Medicine Formula Kai-Xin-San Ameliorates Neuronal Inflammation of CUMS-Induced Depression-like Mice and Reduces the Expressions of Inflammatory Factors via Inhibiting TLR4/IKK/NF-κB Pathways on BV2 Cells

Suchen Qu, Mengqiu Liu, Cheng Cao et al. · Frontiers in Pharmacology · 2021 · 58 citations · Full text

Downregulation of PAK5 inhibits glioma cell migration and invasion potentially through the PAK5-Egr1-MMP2 signaling pathway

Zhengxiang Han, Xiaoxia Wang, Shang-Nuan Zhang et al. · Brain Tumor Pathology · 2013 · 49 citations

Cancer Research, Pak5-egr1-mmp2 Signaling Pathway, Signaling Pathway +10